Multi-Center Randomized Control Trial to Study the Effectiveness of Hyperbaric Oxygen for COVID-19 Patients with Moderate to Severe Respiratory Distress
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Covid-19
-
Age: Between 18 years - 99 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Positive COVID 19 test or clear clinical diagnosis of COVID-19
- Moderate to severe hypoxemia defined by a baseline supplemental oxygen requirement of 6 liters or higher (including high flow oxygenation devices) as measured within the 24 hours before treatment
You may not be eligible for this study if the following are true:
-
- Pregnancy
- Untreated pneumothorax
- Presence of pneumomediastinum, pneumopericardium, significant subcutaneous emphysema, or pulmonary blebs
- Current invasive mechanical ventilation
- Current non-invasive mechanical ventilation (e.g., CPAP, BiPAP)
- Any participants who will not be stable for transport to the hyperbaric chamber
- Those who cannot provide written informed consent
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.